• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对阿芬太尼药代动力学的影响。性别依赖性。

Influence of age on the pharmacokinetics of alfentanil. Gender dependence.

作者信息

Lemmens H J, Burm A G, Hennis P J, Gladines M P, Bovill J G

机构信息

Department of Anesthesiology, University Hospital Leiden, The Netherlands.

出版信息

Clin Pharmacokinet. 1990 Nov;19(5):416-22. doi: 10.2165/00003088-199019050-00005.

DOI:10.2165/00003088-199019050-00005
PMID:2268988
Abstract

Studies on the effects of age on the pharmacokinetics of alfentanil are inconclusive. A possible factor in explaining the differences between various studies could be the effect of gender. The authors studied the effects of age on the pharmacokinetics of alfentanil in female (n = 21) and male (n = 15) patients undergoing lower abdominal surgery under nitrous oxide alfentanil anaesthesia. There was a significant negative correlation (r = -0.79, p less than 0.001) between plasma alfentanil clearance (CL) and age in women (less than 50y, median CL 24.84 L/h; greater than 50y, median CL 14.52 L/h), but not in men (less than 50y, median CL 19.44 L/h; greater than 50y, median CL 16.2 L/h). The conclusion is drawn that the effects of age on the pharmacokinetics of alfentanil are gender-dependent.

摘要

关于年龄对阿芬太尼药代动力学影响的研究尚无定论。解释不同研究之间差异的一个可能因素是性别影响。作者研究了年龄对接受氧化亚氮-阿芬太尼麻醉下腹部手术的女性(n = 21)和男性(n = 15)患者阿芬太尼药代动力学的影响。女性患者血浆阿芬太尼清除率(CL)与年龄之间存在显著负相关(r = -0.79,p小于0.001)(年龄小于50岁,CL中位数为24.84 L/h;年龄大于50岁,CL中位数为14.52 L/h),而男性患者则无此相关性(年龄小于50岁,CL中位数为19.44 L/h;年龄大于50岁,CL中位数为16.2 L/h)。得出的结论是,年龄对阿芬太尼药代动力学的影响具有性别依赖性。

相似文献

1
Influence of age on the pharmacokinetics of alfentanil. Gender dependence.年龄对阿芬太尼药代动力学的影响。性别依赖性。
Clin Pharmacokinet. 1990 Nov;19(5):416-22. doi: 10.2165/00003088-199019050-00005.
2
Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery.
Eur J Anaesthesiol. 1993 Jul;10(4):241-51.
3
Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery.
Can J Anaesth. 1991 Jan;38(1):61-7. doi: 10.1007/BF03009165.
4
[Analgo-sedation in intensive care: a quantitative, EEG-based trial with propofol 1% and 2%].[重症监护中的镇痛镇静:一项基于脑电图的丙泊酚1%和2%定量试验]
Anaesthesist. 1999 Nov;48(11):794-801. doi: 10.1007/s001010050787.
5
Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.阿芬太尼的群体药代动力学:患者的平均剂量-血浆浓度关系及个体间变异性
Anesthesiology. 1987 Jan;66(1):3-12.
6
Age has no effect on the pharmacodynamics of alfentanil.年龄对阿芬太尼的药效学没有影响。
Anesth Analg. 1988 Oct;67(10):956-60.
7
The pharmacokinetics and clinical effects of a low dose of alfentanil in elderly patients.小剂量阿芬太尼在老年患者中的药代动力学及临床效应
Acta Anaesthesiol Belg. 1988;39(1):25-33.
8
Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients.
Anesthesiology. 1998 Mar;88(3):657-67. doi: 10.1097/00000542-199803000-00016.
9
Menopause: pharmacodynamics and pharmacokinetics.
Exp Gerontol. 1994 May-Aug;29(3-4):437-44. doi: 10.1016/0531-5565(94)90023-x.
10
Sex, age and alfentanil pharmacokinetics.
Clin Pharmacokinet. 1991 Jul;21(1):81-2. doi: 10.2165/00003088-199121010-00006.

引用本文的文献

1
Do women need a change in dose of prescription drugs with onset of menopause? Time to find out.女性在绝经开始时需要改变处方药剂量吗?是时候弄清楚了。
BMC Med. 2025 Jul 7;23(1):411. doi: 10.1186/s12916-025-04253-1.
2
Population Pharmacokinetics of Alfentanil in Children.阿芬太尼在儿童中的群体药代动力学
J Clin Pharmacol. 2025 May 16. doi: 10.1002/jcph.70044.
3
Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models.使用动态年龄依赖性生理药代动力学模型预测儿科和老年患者中CYP3A4代谢药物的药代动力学

本文引用的文献

1
Diazepam disposition determinants.地西泮处置的决定因素。
Clin Pharmacol Ther. 1980 Mar;27(3):301-12. doi: 10.1038/clpt.1980.40.
2
Effect of age, gender, and obesity on midazolam kinetics.年龄、性别和肥胖对咪达唑仑动力学的影响。
Anesthesiology. 1984 Jul;61(1):27-35.
3
Clinical pharmacokinetics of fentanyl and its newer derivatives.芬太尼及其新型衍生物的临床药代动力学
Pharmaceutics. 2025 Feb 7;17(2):214. doi: 10.3390/pharmaceutics17020214.
4
Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?新生儿、婴儿及儿童中细胞色素P450介导的肝脏药物清除率预测:现有缩放方法的准确性如何?
Clin Pharmacokinet. 2006;45(1):1-11. doi: 10.2165/00003088-200645010-00001.
5
The influence of age and sex on the clearance of cytochrome P450 3A substrates.年龄和性别对细胞色素P450 3A底物清除率的影响。
Clin Pharmacokinet. 2005;44(1):33-60. doi: 10.2165/00003088-200544010-00002.
6
The distribution and gender difference of CYP3A activity in Chinese subjects.中国受试者中CYP3A活性的分布及性别差异。
Br J Clin Pharmacol. 2003 Mar;55(3):264-9. doi: 10.1046/j.1365-2125.2003.01728.x.
7
Drug dosage in the elderly. Is it rational?老年人的药物剂量。合理吗?
Drugs Aging. 1998 Nov;13(5):357-79. doi: 10.2165/00002512-199813050-00003.
8
Gender differences in pharmacokinetics.药物代谢动力学中的性别差异。
Eur J Drug Metab Pharmacokinet. 1996 Apr-Jun;21(2):123-8. doi: 10.1007/BF03190260.
9
Gender effects in pharmacokinetics and pharmacodynamics.药代动力学和药效学中的性别效应。
Drugs. 1995 Aug;50(2):222-39. doi: 10.2165/00003495-199550020-00003.
10
Sex, age and alfentanil pharmacokinetics.
Clin Pharmacokinet. 1991 Jul;21(1):81-2. doi: 10.2165/00003088-199121010-00006.
Clin Pharmacokinet. 1983 Sep-Oct;8(5):422-46. doi: 10.2165/00003088-198308050-00004.
4
Alfentanil kinetics in the elderly.
Clin Pharmacol Ther. 1984 Aug;36(2):239-43. doi: 10.1038/clpt.1984.169.
5
The pharmacokinetics of alfentanil (R39209): a new opioid analgesic.阿芬太尼(R39209)的药代动力学:一种新型阿片类镇痛药。
Anesthesiology. 1982 Dec;57(6):439-43. doi: 10.1097/00000542-198212000-00002.
6
A safe method for rapidly achieving plasma concentration plateaus.一种快速达到血浆浓度平台期的安全方法。
Clin Pharmacol Ther. 1974 Oct;16(4):691-700. doi: 10.1002/cpt1974164691.
7
Age has no effect on the pharmacodynamics of alfentanil.年龄对阿芬太尼的药效学没有影响。
Anesth Analg. 1988 Oct;67(10):956-60.
8
Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery.在笑气用于下腹部手术时,比较计算机辅助输注与间断推注阿芬太尼作为补充用药的效果。
Anesthesiology. 1988 Jun;68(6):851-61. doi: 10.1097/00000542-198806000-00004.
9
Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.芬太尼和阿芬太尼剂量需求随年龄降低。一项药代动力学和药效学同步评估。
J Pharmacol Exp Ther. 1987 Jan;240(1):159-66.
10
Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.阿芬太尼的群体药代动力学:患者的平均剂量-血浆浓度关系及个体间变异性
Anesthesiology. 1987 Jan;66(1):3-12.